Sagefield Capital’s Chemours CC Stock Holding History

Sagefield Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-157,178	Closed	-$4.41M	–	87
2023 Q3	$4.41M	Buy	+157,178	New	+$5.4M	0.62%	41

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sagefield Capital's CC Position: Q4 2023 in Review

Sagefield Capital sold out of Chemours (CC) in Q4 2023, closing a stake of 157,178 shares — an estimated $4.41M sold.

Sagefield Capital first reported a position in CC in Q3 2023 and held it in 1 quarter. The position peaked at $4.41M in Q3 2023. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

Sagefield Capital reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
Sagefield Capital sold 157,178 Chemours shares in Q4 2023, an estimated $4.41M.
Sagefield Capital first reported a position in Chemours in Q3 2023 and held it in 1 quarter.
Sagefield Capital's Chemours position peaked at $4.41M in Q3 2023.
469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Sagefield Capital's 13F filing for Q4 2023, filed 14 Feb 2024.